Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00445718 · ClinicalTrials.gov registry record
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
A clinical trial of Precancerous Condition and Adrenocortical Carcinoma, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 97
- Enrollment target
- 20
- Study locations
NCT00445718: Completed study of Precancerous Condition and Adrenocortical Carcinoma, sponsored by Children's Oncology Group.
NCT00445718 is a study of Precancerous Condition and Adrenocortical Carcinoma that has completed, run by Children's Oncology Group. The registered enrollment target is 97 participants, below the 616-participant average among 15 other Precancerous Condition trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00445718, a study of Precancerous Condition and Adrenocortical Carcinoma, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 20
- Study locations
Study Summary
This natural history study is collecting health information about infants with adrenal masses found on prenatal and/or neonatal imaging. Gathering information over time from imaging and laboratory tests of infants with adrenal masses may help doctors learn more about the disease and plan the best treatment.
Primary Outcome
Estimated using the Kaplan-Meier method.
Conditions Studied
Interventions
- PROCEDURE computed tomography
- PROCEDURE 3-Tesla magnetic resonance imaging
- PROCEDURE Abdominal Sonogram
Study Locations (20)
New York
- Brooklyn Hospital Center - Brooklyn
- The Steven and Alexandra Cohen Children's Medical Center of New York - New Hyde Park
- Columbia University Medical Center - New York
- University of Rochester - Rochester
Illinois
- Childrens Memorial Hospital - Chicago
- Advocate Lutheran General Hospital - Park Ridge
- Southern Illinois University - Springfield
New Jersey
- Saint Peter's University Hospital - New Brunswick
- Newark Beth Israel Medical Center - Newark
- Saint Joseph's Regional Medical Center - Paterson
California
- Southern California Permanente Medical Group - Downey
- Children's Hospital Los Angeles - Los Angeles
Massachusetts
- Dana-Farber Cancer Institute - Boston
- University of Massachusetts Medical School - Worcester
Arizona
- University of Arizona Health Sciences Center - Tucson
Colorado
- Children's Hospital Colorado - Aurora
Delaware
- Alfred I duPont Hospital for Children - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2001-07 |
| Est. Completion | 2013-01 |
What the finished NCT00445718 record still lists
NCT00445718 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 616-participant average among 15 other Precancerous Condition trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Precancerous Condition appearing as the primary indexed condition, and to 3 interventions - of which computed tomography is the first listed.
NCT00445718 names 20 study sites across 11 states, led by New York, Illinois, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00445718 about?
NCT00445718 is a clinical study titled "Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging". This natural history study is collecting health information about infants with adrenal masses found on prenatal and/or neonatal imaging. Gathering information over time from imaging and laboratory tests of infants with adrenal masses may help doctors learn more about the disease and plan the best tr...
What is the current status of trial NCT00445718?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2001-07. Estimated completion is 2013-01.
What conditions does trial NCT00445718 study?
This clinical trial studies the following conditions: Precancerous Condition, Adrenocortical Carcinoma, Localized Resectable Neuroblastoma.
What interventions are being tested in trial NCT00445718?
The interventions under investigation include: computed tomography (PROCEDURE), 3-Tesla magnetic resonance imaging (PROCEDURE), Abdominal Sonogram (PROCEDURE).
Who is sponsoring clinical trial NCT00445718?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00445718 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Delaware, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Precancerous Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00445718's enrollment target sits among peer trials
97 11th of 15 higher than 5 of 15 other Precancerous Condition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Precancerous Condition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RECRUITING
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
RECRUITING
-
Lovastatin in Treating Patients At High Risk of Melanoma
COMPLETED · Phase 2
-
Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers
COMPLETED
-
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
COMPLETED · NA
-
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia